{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:09:50Z","timestamp":1780391390202,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,26]]},"DOI":"10.7759\/cureus.72427","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T15:25:11Z","timestamp":1729956311000},"source":"Crossref","is-referenced-by-count":7,"title":["Neurodegenerative Disorders and the Gut-Microbiome-Brain Axis: A Literature Review"],"prefix":"10.7759","author":[{"given":"Bindu Jyothi","family":"Dandamudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrina Antheia M","family":"Dimaano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nensi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamah","family":"AlQassab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Al-Sulaitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Nelakuditi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05892-0","article-title":"Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference","volume":"9","author":"Young AL","year":"2018","unstructured":"Young AL, Marinescu RV, Oxtoby NP, et al.. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat Commun. 2018, 9:4273. 10.1038\/s41467-018-05892-0","journal-title":"Nat Commun"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown RH","year":"2017","unstructured":"Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017, 377:162-72. 10.1056\/NEJMra1603471","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.03.007","article-title":"Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?","volume":"25","author":"Bayer TA","year":"2015","unstructured":"Bayer TA. Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?. Eur Neuropsychopharmacol. 2015, 25:713-24. 10.1016\/j.euroneuro.2013.03.007","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","unstructured":"Structure, function and diversity of the healthy human microbiome. Nature. 2012, 486.207-14. 10.1038\/nature11234","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/me.2014-1108","article-title":"Minireview: Gut microbiota: the neglected endocrine organ","volume":"28","author":"Clarke G","year":"2014","unstructured":"Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014, 28:1221-38. 10.1210\/me.2014-1108","journal-title":"Mol Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01353","article-title":"The immune system bridges the gut microbiota with systemic energy homeostasis: focus on TLRs, mucosal barrier, and SCFAs","volume":"8","author":"Spiljar M","year":"2017","unstructured":"Spiljar M, Merkler D, Trajkovski M. The immune system bridges the gut microbiota with systemic energy homeostasis: focus on TLRs, mucosal barrier, and SCFAs. Front Immunol. 2017, 8:1353. 10.3389\/fimmu.2017.01353","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00716","article-title":"Systems biology approaches to understand the host-microbiome interactions in neurodegenerative diseases","volume":"14","author":"Rosario D","year":"2020","unstructured":"Rosario D, Boren J, Uhlen M, Proctor G, Aarsland D, Mardinoglu A, Shoaie S. Systems biology approaches to understand the host-microbiome interactions in neurodegenerative diseases. Front Neurosci. 2020, 14:716. 10.3389\/fnins.2020.00716","journal-title":"Front Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.129","article-title":"Host response: a trigger for neurodegeneration?","volume":"1","author":"Stilling RM","year":"2016","unstructured":"Stilling RM, Cryan JF. Host response: a trigger for neurodegeneration?. Nat Microbiol. 2016, 1:16129. 10.1038\/nmicrobiol.2016.129","journal-title":"Nat Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-142841","article-title":"Mechanisms of molecular mimicry involving the microbiota in neurodegeneration","volume":"45","author":"Friedland RP","year":"2015","unstructured":"Friedland RP. Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J Alzheimers Dis. 2015, 45:349-62. 10.3233\/JAD-142841","journal-title":"J Alzheimers Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00138","article-title":"Exploring the \"multiple-hit hypothesis\" of neurodegenerative disease: bacterial infection comes up to bat","volume":"9","author":"Patrick KL","year":"2019","unstructured":"Patrick KL, Bell SL, Weindel CG, Watson RO. Exploring the \"multiple-hit hypothesis\" of neurodegenerative disease: bacterial infection comes up to bat. Front Cell Infect Microbiol. 2019, 9:138. 10.3389\/fcimb.2019.00138","journal-title":"Front Cell Infect Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nature14547","article-title":"\u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts W","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, et al.. \u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 2015, 522:340-4. 10.1038\/nature14547","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2016.04.016","article-title":"Development of the intrinsic and extrinsic innervation of the gut","volume":"417","author":"Uesaka T","year":"2016","unstructured":"Uesaka T, Young HM, Pachnis V, Enomoto H. Development of the intrinsic and extrinsic innervation of the gut. Dev Biol. 2016, 417:158-67. 10.1016\/j.ydbio.2016.04.016","journal-title":"Dev Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2017.1349041","article-title":"Gut microbiome in multiple sclerosis: the players involved and the roles they play","volume":"8","author":"Shahi SK","year":"2017","unstructured":"Shahi SK, Freedman SN, Mangalam AK. Gut microbiome in multiple sclerosis: the players involved and the roles they play. Gut Microbes. 2017, 8:607-15. 10.1080\/19490976.2017.1349041","journal-title":"Gut Microbes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng D","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020, 30:492-506. 10.1038\/s41422-020-0332-7","journal-title":"Cell Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00279","article-title":"The peripheral immune system and amyotrophic lateral sclerosis","volume":"11","author":"McCombe PA","year":"2020","unstructured":"McCombe PA, Lee JD, Woodruff TM, Henderson RD. The peripheral immune system and amyotrophic lateral sclerosis. Front Neurol. 2020, 11:279. 10.3389\/fneur.2020.00279","journal-title":"Front Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9040820","article-title":"The impact of norepinephrine on mono-species and dual-species staphylococcal biofilms","volume":"9","author":"Mart'yanov SV","year":"2021","unstructured":"Mart'yanov SV, Botchkova EA, Plakunov VK, Gannesen AV. The impact of norepinephrine on mono-species and dual-species staphylococcal biofilms. Microorganisms. 2021, 9:820. 10.3390\/microorganisms9040820","journal-title":"Microorganisms"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2942","article-title":"An integrated catalog of reference genes in the human gut microbiome","volume":"32","author":"Li J","year":"2014","unstructured":"Li J, Jia H, Cai X, et al.. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol. 2014, 32:834-41. 10.1038\/nbt.2942","journal-title":"Nat Biotechnol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella E","year":"2019","unstructured":"Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GA, Gasbarrini A, Mele MC. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019, 7:14. 10.3390\/microorganisms7010014","journal-title":"Microorganisms"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00460-0","article-title":"The gut microbiota-brain axis in behaviour and brain disorders","volume":"19","author":"Morais LH","year":"2021","unstructured":"Morais LH, Schreiber HL 4th, Mazmanian SK. The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2021, 19:241-55. 10.1038\/s41579-020-00460-0","journal-title":"Nat Rev Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann ER","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024, 24:577-95. 10.1038\/s41577-024-01014-8","journal-title":"Nat Rev Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1102999108","article-title":"Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve","volume":"108","author":"Bravo JA","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV, et al.. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011, 108:16050-5. 10.1073\/pnas.1102999108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2174\/1381612053381684","article-title":"Blood-brain barrier transport of cytokines: a mechanism for neuropathology","volume":"11","author":"Banks WA","year":"2005","unstructured":"Banks WA. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des. 2005, 11:973-84. 10.2174\/1381612053381684","journal-title":"Curr Pharm Des"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-016-0338-6","article-title":"Human gut microbiota: the links with dementia development","volume":"8","author":"Alkasir R","year":"2017","unstructured":"Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell. 2017, 8:90-102. 10.1007\/s13238-016-0338-6","journal-title":"Protein Cell"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.4","article-title":"Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism","volume":"48","author":"Roh E","year":"2016","unstructured":"Roh E, Song DK, Kim MS. Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism. Exp Mol Med. 2016, 48:e216. 10.1038\/emm.2016.4","journal-title":"Exp Mol Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/biology12020195","article-title":"From dysbiosis to neurodegenerative diseases through different communication pathways: an overview","volume":"12","author":"Intili G","year":"2023","unstructured":"Intili G, Paladino L, Rappa F, et al.. From dysbiosis to neurodegenerative diseases through different communication pathways: an overview. Biology (Basel). 2023, 12:10.3390\/biology12020195","journal-title":"Biology (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101806","article-title":"Microbiota-gut-brain axis in health and disease: is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?","volume":"191","author":"Pellegrini C","year":"2020","unstructured":"Pellegrini C, Antonioli L, Calderone V, Colucci R, Fornai M, Blandizzi C. Microbiota-gut-brain axis in health and disease: is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?. Prog Neurobiol. 2020, 191:101806. 10.1016\/j.pneurobio.2020.101806","journal-title":"Prog Neurobiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13601-y","article-title":"Gut microbiome alterations in Alzheimer's disease","volume":"7","author":"Vogt NM","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, et al.. Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017, 7:13537. 10.1038\/s41598-017-13601-y","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.08.019","article-title":"Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly","volume":"49","author":"Cattaneo A","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, et al.. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017, 49:60-8. 10.1016\/j.neurobiolaging.2016.08.019","journal-title":"Neurobiol Aging"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316844","article-title":"Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice","volume":"68","author":"Perez-Pardo P","year":"2019","unstructured":"Perez-Pardo P, Dodiya HB, Engen PA, et al.. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice. Gut. 2019, 68:829-43. 10.1136\/gutjnl-2018-316844","journal-title":"Gut"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70094-6","article-title":"Multiple sclerosis: risk factors, prodromes, and potential causal pathways","volume":"9","author":"Ramagopalan SV","year":"2010","unstructured":"Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010, 9:727-39. 10.1016\/S1474-4422(10)70094-6","journal-title":"Lancet Neurol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-014-0492-2","article-title":"Gut microbiome and multiple sclerosis","volume":"14","author":"Bhargava P","year":"2014","unstructured":"Bhargava P, Mowry EM. Gut microbiome and multiple sclerosis. Curr Neurol Neurosci Rep. 2014, 14:492. 10.1007\/s11910-014-0492-2","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2017.08.008","article-title":"The dynamics of the gut microbiome in multiple sclerosis in relation to disease","volume":"36","author":"Mowry EM","year":"2018","unstructured":"Mowry EM, Glenn JD. The dynamics of the gut microbiome in multiple sclerosis in relation to disease. Neurol Clin. 2018, 36:185-96. 10.1016\/j.ncl.2017.08.008","journal-title":"Neurol Clin"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/srep28484","article-title":"Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls","volume":"6","author":"Chen J","year":"2016","unstructured":"Chen J, Chia N, Kalari KR, et al.. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep. 2016, 6:28484. 10.1038\/srep28484","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2019.1623026","article-title":"Gut microbiota in ALS: possible role in pathogenesis?","volume":"19","author":"McCombe PA","year":"2019","unstructured":"McCombe PA, Henderson RD, Lee A, et al.. Gut microbiota in ALS: possible role in pathogenesis?. Expert Rev Neurother. 2019, 19:785-805. 10.1080\/14737175.2019.1623026","journal-title":"Expert Rev Neurother"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/1099800418784202","article-title":"Potential role of the gut microbiome in ALS: a systematic review","volume":"20","author":"Wright ML","year":"2018","unstructured":"Wright ML, Fournier C, Houser MC, Tansey M, Glass J, Hertzberg VS. Potential role of the gut microbiome in ALS: a systematic review. Biol Res Nurs. 2018, 20:513-21. 10.1177\/1099800418784202","journal-title":"Biol Res Nurs"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01479","article-title":"Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing","volume":"7","author":"Fang X","year":"2016","unstructured":"Fang X, Wang X, Yang S, Meng F, Wang X, Wei H, Chen T. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front Microbiol. 2016, 7:1479. 10.3389\/fmicb.2016.01479","journal-title":"Front Microbiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald ME","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, et al.. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993, 72:971-83. 10.1016\/0092-8674(93)90585-E","journal-title":"Cell"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.09.001","article-title":"Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease","volume":"135","author":"Kong G","year":"2020","unstructured":"Kong G, Cao KL, Judd LM, Li S, Renoir T, Hannan AJ. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease. Neurobiol Dis. 2020, 135:104268. 10.1016\/j.nbd.2018.09.001","journal-title":"Neurobiol Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9478630","article-title":"Probiotic species in the modulation of gut microbiota: an overview","volume":"2018","author":"Azad MA","year":"2018","unstructured":"Azad MA, Sarker M, Li T, Yin J. Probiotic species in the modulation of gut microbiota: an overview. Biomed Res Int. 2018, 2018:9478630. 10.1155\/2018\/9478630","journal-title":"Biomed Res Int"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1179\/174313208X327964","article-title":"The expression of glutamate transporters in chest compression-induced audiogenic epilepsy: a comparative study","volume":"30","author":"Lu Z","year":"2008","unstructured":"Lu Z, Zhang W, Zhang N, Jiang J, Luo Q, Qiu Y. The expression of glutamate transporters in chest compression-induced audiogenic epilepsy: a comparative study. Neurol Res. 2008, 30:915-9. 10.1179\/174313208X327964","journal-title":"Neurol Res"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00256","article-title":"Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial","volume":"8","author":"Akbari E","year":"2016","unstructured":"Akbari E, Asemi Z, Daneshvar Kakhaki R, et al.. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial. Front Aging Neurosci. 2016, 8:256. 10.3389\/fnagi.2016.00256","journal-title":"Front Aging Neurosci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00662","article-title":"Does severity of Alzheimer's disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial","volume":"9","author":"Agahi A","year":"2018","unstructured":"Agahi A, Hamidi GA, Daneshvar R, et al.. Does severity of Alzheimer's disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial. Front Neurol. 2018, 9:662. 10.3389\/fneur.2018.00662","journal-title":"Front Neurol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.11.034","article-title":"Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: a randomized, double-blind, controlled trial","volume":"38","author":"Tamtaji OR","year":"2019","unstructured":"Tamtaji OR, Heidari-Soureshjani R, Mirhosseini N, et al.. Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: a randomized, double-blind, controlled trial. Clin Nutr. 2019, 38:2569-75. 10.1016\/j.clnu.2018.11.034","journal-title":"Clin Nutr"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/nu11020305","article-title":"Efficacy and safety of Lactobacillus plantarum C29-fermented soybean (DW2009) in individuals with mild cognitive impairment: a 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial","volume":"11","author":"Hwang YH","year":"2019","unstructured":"Hwang YH, Park S, Paik JW, et al.. Efficacy and safety of Lactobacillus plantarum C29-fermented soybean (DW2009) in individuals with mild cognitive impairment: a 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial. Nutrients. 2019, 11:305. 10.3390\/nu11020305","journal-title":"Nutrients"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.602204","article-title":"Expression of concern: effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial","volume":"12","author":"Akbari E","year":"2020","unstructured":"Akbari E, Asemi Z, Daneshvar Kakhaki R, et al.. Expression of concern: effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial. Front Aging Neurosci. 2020, 12:602204. 10.3389\/fnagi.2020.602204","journal-title":"Front Aging Neurosci"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.05.018","article-title":"Clinical and metabolic response to probiotic administration in people with Parkinson's disease: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Tamtaji OR","year":"2019","unstructured":"Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R, et al.. Clinical and metabolic response to probiotic administration in people with Parkinson's disease: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2019, 38:1031-5. 10.1016\/j.clnu.2018.05.018","journal-title":"Clin Nutr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-220148","article-title":"Effect of probiotic Bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: results of a 24-week randomized, double-blind, placebo-controlled trial","volume":"88","author":"Asaoka D","year":"2022","unstructured":"Asaoka D, Xiao J, Takeda T, et al.. Effect of probiotic Bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: results of a 24-week randomized, double-blind, placebo-controlled trial. J Alzheimers Dis. 2022, 88:75-95. 10.3233\/JAD-220148","journal-title":"J Alzheimers Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01607-9","article-title":"A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis","volume":"18","author":"Di Gioia D","year":"2020","unstructured":"Di Gioia D, Bozzi Cionci N, Baffoni L, et al.. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC Med. 2020, 18:153. 10.1186\/s12916-020-01607-9","journal-title":"BMC Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1103189","article-title":"Preliminary evidence for developing safe and efficient fecal microbiota transplantation as potential treatment for aged related cognitive impairments","volume":"13","author":"Chen X","year":"2023","unstructured":"Chen X, Zhang W, Lin Z, Zheng C, Chen S, Zhou H, Liu Z. Preliminary evidence for developing safe and efficient fecal microbiota transplantation as potential treatment for aged related cognitive impairments. Front Cell Infect Microbiol. 2023, 13:1103189. 10.3389\/fcimb.2023.1103189","journal-title":"Front Cell Infect Microbiol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1104759","article-title":"Fecal microbiota transplantation in Parkinson's disease-a randomized repeat-dose, placebo-controlled clinical pilot study","volume":"14","author":"DuPont HL","year":"2023","unstructured":"DuPont HL, Suescun J, Jiang ZD, et al.. Fecal microbiota transplantation in Parkinson's disease-a randomized repeat-dose, placebo-controlled clinical pilot study. Front Neurol. 2023, 14:1104759. 10.3389\/fneur.2023.1104759","journal-title":"Front Neurol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106791","article-title":"Fecal microbiota transplant as a potential treatment for Parkinson's disease - a case series","volume":"207","author":"Segal A","year":"2021","unstructured":"Segal A, Zlotnik Y, Moyal-Atias K, Abuhasira R, Ifergane G. Fecal microbiota transplant as a potential treatment for Parkinson's disease - a case series. Clin Neurol Neurosurg. 2021, 207:106791. 10.1016\/j.clineuro.2021.106791","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/296418-neurodegenerative-disorders-and-the-gut-microbiome-brain-axis-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T15:25:13Z","timestamp":1729956313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/296418-neurodegenerative-disorders-and-the-gut-microbiome-brain-axis-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.72427","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,26]]}}}